Many studies showed the evidence for the pathogenic role of TLR4/LPS signaling in the progression of alcoholic and nonalcoholic fatty liver diseases [ALD, non-alcoholic fatty liver disease (NAFLD)] and hepatocellular carcinoma (3, 11, 12). This evidence concerns the gene TLR4 and hepatocellular carcinoma.